Literature DB >> 8543373

Nitric oxide and interleukin-8 as inflammatory components of cystic fibrosis.

C Francoeur1, M Denis.   

Abstract

We examined the production of reactive nitrogen intermediates in the tracheo-bronchial tree of patients with cystic fibrosis (CF). Examination of the soluble phase of sputa from 17 CF patients revealed the presence of high levels of NO2-/NO3- assayed by the Greiss reaction. We also examined the presence of the chemotactic cytokine interleukin-8 (IL-8) in these samples so as to assess another important inflammatory marker; high levels of IL-8 were present in the sputa of cystic fibrosis subjects. The elevated nitrite was not produced by the presence of Pseudomonas bacteria in the sputa, inasmuch as bacteria in culture released undetectable amounts of nitrite in culture media. Neutrophils from the sputa of CF patients with disease exacerbation released higher amounts of nitrite and IL-8. Neutrophils from the sputa were also shown to spontaneously release substantial amounts of nitrite in the supernatants, and this release was partly blocked by the antagonist NG-mono-methyl-L-arginine (L-NMMA). Blood neutrophils were shown to release nitrite only in response to challenge with CF-associated strains of Pseudomonas, and not exposure to cytokines. There was no significant differences in nitrite release between normal and CF blood polymorphonuclear leucocytes (PMNs). A study of upper airway epithelial cell lines showed that these cells released low amounts of nitrite after infection with CF-associated strains of Pseudomonas but not after cytokine exposure. Epithelial cell lines with CF or normal phenotypes were shown to release similar quantities of nitrite, upon stimulation with Pseudomonas. These data demonstrate that elevated levels of reactive nitrogen intermediates and IL-8 are produced in the tracheo-bronchial tree of subjects with CF. Levels of IL-8 and nitrite were higher in the secretions of CF subjects with disease exacerbation. The involvement of nitric oxide and other reactive nitrogen intermediates produced by neutrophils and other cells in the tissue damaging processes in CF deserves further investigation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8543373     DOI: 10.1007/bf01539138

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  19 in total

Review 1.  Endogenous nitric oxide: physiology, pathology and clinical relevance.

Authors:  S Moncada; E A Higgs
Journal:  Eur J Clin Invest       Date:  1991-08       Impact factor: 4.686

Review 2.  Nitric oxide: physiology, pathophysiology, and pharmacology.

Authors:  S Moncada; R M Palmer; E A Higgs
Journal:  Pharmacol Rev       Date:  1991-06       Impact factor: 25.468

3.  Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide.

Authors:  J S Beckman; T W Beckman; J Chen; P A Marshall; B A Freeman
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

4.  Expression of normal and cystic fibrosis phenotypes by continuous airway epithelial cell lines.

Authors:  D M Jefferson; J D Valentich; F C Marini; S A Grubman; M C Iannuzzi; H L Dorkin; M Li; K W Klinger; M J Welsh
Journal:  Am J Physiol       Date:  1990-12

5.  Alternate-day prednisone reduces morbidity and improves pulmonary function in cystic fibrosis.

Authors:  H S Auerbach; M Williams; J A Kirkpatrick; H R Colten
Journal:  Lancet       Date:  1985-09-28       Impact factor: 79.321

6.  Release of interleukin-8, interleukin-6, and colony-stimulating factors by upper airway epithelial cells: implications for cystic fibrosis.

Authors:  M Bédard; C D McClure; N L Schiller; C Francoeur; A Cantin; M Denis
Journal:  Am J Respir Cell Mol Biol       Date:  1993-10       Impact factor: 6.914

Review 7.  Immunologic aspects of cystic fibrosis.

Authors:  G Döring; A Albus; N Høiby
Journal:  Chest       Date:  1988-08       Impact factor: 9.410

8.  Evidence for reactive nitrogen intermediates in killing of staphylococci by human neutrophil cytoplasts. A new microbicidal pathway for polymorphonuclear leukocytes.

Authors:  S E Malawista; R R Montgomery; G van Blaricom
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

9.  Nitrite production by stimulated human polymorphonuclear leukocytes supplemented with azide and catalase.

Authors:  S J Klebanoff; C F Nathan
Journal:  Biochem Biophys Res Commun       Date:  1993-11-30       Impact factor: 3.575

10.  Pore-forming bacterial toxins potently induce release of nitric oxide in porcine endothelial cells.

Authors:  N Suttorp; M Fuhrmann; S Tannert-Otto; F Grimminger; S Bhadki
Journal:  J Exp Med       Date:  1993-07-01       Impact factor: 14.307

View more
  13 in total

1.  Interaction of pseudomonas aeruginosa with epithelial cells: identification of differentially regulated genes by expression microarray analysis of human cDNAs.

Authors:  J K Ichikawa; A Norris; M G Bangera; G K Geiss; A B van 't Wout; R E Bumgarner; S Lory
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-15       Impact factor: 11.205

2.  Nitrite reductase from Pseudomonas aeruginosa induces inflammatory cytokines in cultured respiratory cells.

Authors:  K Oishi; B Sar; A Wada; Y Hidaka; S Matsumoto; H Amano; F Sonoda; S Kobayashi; T Hirayama; T Nagatake; K Matsushima
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

3.  Nitric oxide production by polymorphonuclear leucocytes in infected cystic fibrosis sputum consumes oxygen.

Authors:  M Kolpen; T Bjarnsholt; C Moser; C R Hansen; L F Rickelt; M Kühl; C Hempel; T Pressler; N Høiby; P Ø Jensen
Journal:  Clin Exp Immunol       Date:  2014-07       Impact factor: 4.330

4.  Polymorphonuclear leukocytes restrict growth of Pseudomonas aeruginosa in the lungs of cystic fibrosis patients.

Authors:  Kasper N Kragh; Morten Alhede; Peter Ø Jensen; Claus Moser; Thomas Scheike; Carsten S Jacobsen; Steen Seier Poulsen; Steffen Robert Eickhardt-Sørensen; Hannah Trøstrup; Lars Christoffersen; Hans-Petter Hougen; Lars F Rickelt; Michael Kühl; Niels Høiby; Thomas Bjarnsholt
Journal:  Infect Immun       Date:  2014-08-11       Impact factor: 3.441

Review 5.  Monitoring inflammation in CF. Cytokines.

Authors:  Scott D Sagel; Frank J Accurso
Journal:  Clin Rev Allergy Immunol       Date:  2002-08       Impact factor: 8.667

6.  Expression of S100A12 (EN-RAGE) in cystic fibrosis.

Authors:  D Foell; S Seeliger; T Vogl; H-G Koch; H Maschek; E Harms; C Sorg; J Roth
Journal:  Thorax       Date:  2003-07       Impact factor: 9.139

7.  Faster activation of polymorphonuclear neutrophils in resistant mice during early innate response to Pseudomonas aeruginosa lung infection.

Authors:  P Ø Jensen; C Moser; O Kobayashi; H P Hougen; A Kharazmi; N Høiby
Journal:  Clin Exp Immunol       Date:  2004-09       Impact factor: 4.330

8.  Digitoxin mimics gene therapy with CFTR and suppresses hypersecretion of IL-8 from cystic fibrosis lung epithelial cells.

Authors:  Meera Srivastava; Ofer Eidelman; Jian Zhang; Cloud Paweletz; Hung Caohuy; QingFeng Yang; Kenneth A Jacobson; Eliahu Heldman; Wei Huang; Catherine Jozwik; Bette S Pollard; Harvey B Pollard
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-10       Impact factor: 11.205

9.  Inducible NO synthase expression is low in airway epithelium from young children with cystic fibrosis.

Authors:  A Moeller; F Horak; C Lane; D Knight; A Kicic; S Brennan; P Franklin; J Terpolilli; J H Wildhaber; S M Stick
Journal:  Thorax       Date:  2006-03-03       Impact factor: 9.139

Review 10.  Sputum biomarkers of inflammation in cystic fibrosis lung disease.

Authors:  Scott D Sagel; James F Chmiel; Michael W Konstan
Journal:  Proc Am Thorac Soc       Date:  2007-08-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.